For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

By Dr. Liji Thomas, MD New data from six European countries reveals the true toll of respiratory syncytial virus on older ...

The strategies that the industry’s lobbyists use, or don’t deploy, matter as the Trump administration moves more decisively ...

In adults 50 and older, Moderna’s flu shot was more than 26% better than an unspecified commercial vaccine. In May, the ...

Some members of the scientific community have concern that they’re coming out of the COVID pandemic—exposure to the virus, ...

Dr. Todd Ellerin, Vice Chair of Department of Medicine of South Shore Health discusses the new FDA warning regarding Pfizer and Moderna COVID-19 vaccines.The FDA is expanding warnings on Pfizer and ...

A new CDC vaccine panel, handpicked by RFK Jr., released an updated list of recommended vaccines. However, only if the ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

A startling new vision of vaccination in America is becoming clearer — one likely to involve fresh scrutiny of established science and practices, and limits on vaccines that have been studied for ...

He claimed that Gavi had “ignored the science” about vaccine safety. He had already dismissed all seventeen members of the C.D.C.’s Advisory Committee on Immunization Practices, before saying that his ...